Copyright © 2009 Chun Li Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. M. S. Lu, “Anti-cancer effect of tonic traditional Chinese medicine and organic germanium,” Trace Elements Science, vol. 5, pp. 57–59, 1998.
2. H. Aso, F. Suzuki, T. Yamaguchi, Y. Hayashi, T. Ebina, and N. Ishida, “Induction of interferon and activation of NK cells and macrophages in mice by oral administration of Ge-132, an organic germanium compound,” Microbiology and Immunology, vol. 29, no. 1, pp. 65–74, 1985.
3. F. Suzuki, “Antitumor activity of Ge-132, a new organogermanium compound, in mice is expressed through the functions of macrophages and T lymphocytes,” Japanese Journal of Cancer and Chemotherapy, vol. 12, no. 7, pp. 1445–1452, 1985.
4. M. Kuwabara, S. Ohba, and M. Yukawa, “Effect of germanium, poly-trans-[2-carboxyethyl] germasesquioxane on natural killer (NK) activity in dogs,” Journal of Veterinary Medical Science, vol. 64, no. 8, pp. 719–721, 2002. View at Publisher · View at Google Scholar
5. B. J. Kaplan, W. W. Parish, G. M. Andrus, J. S. A. Simpson, and C. J. Field, “Germane facts about germanium sesquioxide: I. Chemistry and anticancer properties,” The Journal of Alternative and Complementary Medicine, vol. 10, no. 2, pp. 337–344, 2004. View at Publisher · View at Google Scholar · View at PubMed
6. G. B. Gerber and A. Léonard, “Mutagenicity, carcinogenicity and teratogenicity of germanium compounds,” Mutation Research/Reviews in Mutation Research, vol. 387, no. 3, pp. 141–146, 1997. View at Publisher · View at Google Scholar
7. Y. Q. Ma, J. S. Li, Z. N. Xuan, and R. C. Liu, “Synthesis, characterization and antitumor activity of some arylantimony triphenylgermanylpropionates and crystal structures of ${\text{Ph}}_{\text{3}}{\text{GeCH(Ph)CH}}_2{\text{CO}}_2{\text{SbPh}}_4$ and ${{\text{[Ph}}_{\text{3}}{\text{GeCH}}_{\text{2}}{\text{CH(CH}}_{\text{3}}{\text{)CO}}_{\text{2}}\text{]}}_{\text{2}}{\text{Sb(4-ClC}}_{\text{6}}{\text{H}}_{\text{4}}{\text{)}}_{\text{3}}$,” Journal of Organometallic Chemistry, vol. 620, no. 1-2, pp. 235–242, 2001. View at Publisher · View at Google Scholar
8. G. Shangguan, F. Xing, X. Qu, et al., “DNA binding specificity and cytotoxicity of novel antitumor agent Ge132 derivatives,” Bioorganic & Medicinal Chemistry Letters, vol. 15, no. 12, pp. 2962–2965, 2005. View at Publisher · View at Google Scholar · View at PubMed
9. B. G. Wang, G. Y. Zhang, L. Y. Zhao, and Y. Liu, “Inhibiting effect of organic germanium polyacid derivative on S180 cells,” Journal of Xi'an Jiaotong University (Medical Sciences), vol. 23, pp. 550–551, 2002.
10. L. Ye and W. Zhang, “Synthesis and biological activity of 3-(2, 8, 9-trioxa-aza-1-germatricyclo [3. 3. 3. 0]undecane-1-yl)-hydroxycinnamic acids,” Medicinal Chemistry, vol. 3, no. 5, pp. 466–468, 2007. View at Publisher · View at Google Scholar
11. E. Abele, R. Abele, P. Arsenyan, et al., “Synthesis and cytotoxicity of silicon and germanium containing pyridine oxime O-ethers,” Bioinorganic Chemistry and Applications, vol. 1, no. 3-4, pp. 299–308, 2004. View at Publisher · View at Google Scholar · View at PubMed
12. E. Lukevics, P. Arsenyan, I. Shestakova, et al., “Cytotoxic activity of silyl- and germyl-substituted 4,4-dioxo-3a,6a- dihydrothieno[2,3-d]isoxazolines-2,” Metal-Based Drugs, vol. 7, no. 2, pp. 63–66, 2000. View at Publisher · View at Google Scholar · View at PubMed
13. L. B. Ye, X. D. Chen, H. Zhao, and X. M. Yan, “The inhibitory effect of germanium ferulic acid on the tumor ${\text{U}}_{14}$,” Anhui Medical and Pharmaceutical Journal, vol. 9, pp. 570–571, 2005.
14. K. Li, X. F. Zhu, Y. Ye, and Q. Zeng, “The research development of organogermanium compound on antitumor activity,” Speciality Petrochemicals, vol. 3, pp. 54–57, 2003.
15. Z. Rappoport, The Chemistry of Organic Germanium Tin and Lead Compounds. Vol. 2, John Wiley & Sons, Chichester, UK, 2002.
16. M. Gielen and E. R. T. Tiekink, Eds., Metallotherapeutic Drugs and Metal-Based Diagnostic Agents, M. Gielen and E. R. T. Tiekink, Eds., John Wiley & Sons, Chichester, UK, 2005.
17. A. P. Li, A. R. Dahl, and J. O. Hill, “In vitro cytotoxicity and genotoxicity of dibutyltin dichloride and dibutylgermanium dichloride,” Toxicology and Applied Pharmacology, vol. 64, no. 3, pp. 482–485, 1982. View at Publisher · View at Google Scholar
18. B. T. Hill, S. A. Whatley, A. S. Bellamy, L. Y. Jenkins, and R. D. H. Whelan, “Cytotoxic effect and biological activity of 2-aza-8-germanospiro[4,5]-decane-2-propanamine-8,8-diethyl-N,N-dimethyl dichloride [NSC 192965; spirogermanium] in vitro,” Cancer Research, vol. 42, pp. 2852–2856, 1982.
19. G.-Y. Bao, S. Liu, and T.-H. Li, “Synthesis, ${}^{99\text{m}}\text{T}\text{c}$-labeled and biodistribution study of $\gamma$-thioureidopropyl germanium sesquisulfide,” Journal of Nuclear and Radiochemistry, vol. 24, no. 4, pp. 240–242, 2002.
20. T. H. Li and H. S. Niu, “Synthesis of new type of organogermanium sesquioxides, ${}^{99\text{m}}\text{T}\text{c}$ labelling and their tissue distribution in mice,” Journal of Labelled Compounds and Radiopharmaceuticals, vol. 42, p. S607, 1999.
21. J. H. Zhou, G. Q. Shangguan, and G. H. Wang, “The synthesis and Cytotoxic activity of novel no germanium sesquioxides with naphthalene moiety,” Journal of Mathematical Medicine, vol. 20, pp. 699–701, 2007.
22. C. M. Rink, M. C. Mauck, I. Asif, M. E. Pitzer, and E. E. Fenlon, “Syntheses of silatranyl- and germatranyluridines,” Organic Letters, vol. 7, no. 6, pp. 1165–1168, 2005. View at Publisher · View at Google Scholar · View at PubMed
23. R. Y. Chen, L. J. Mao, and M. Zhang, “Condensation reaction of $\beta$-triphenylgermanyl propionic acid with $\alpha$-hydroxy phosphonic ester and the structure of the products,” Science in China-Series B, vol. 38, no. 8, pp. 897–902, 1995.
24. Y. Ye, Q. Zeng, and L. Z. Liu, “The synthesis of N-($\beta$-triphenylgermanyl) propionyl-$\alpha$- amino-benzylphosphonates,” Synthetic Communications, vol. 31, no. 15, pp. 2373–2378, 2001. View at Publisher · View at Google Scholar
25. Y. Ye, Q. Zeng, and Q.-M. Wang, “Synthesis and crystal structure of O,O-dimethyl-N-($\beta$-triphenylgermanyl)propionyl-$\alpha$ -aminobenzylphosphonates,” Chinese Journal of Structural Chemistry, vol. 20, no. 3, pp. 195–198, 2001.
26. R. T. Dorr and D. D. Van Hoff, Cancer Chemotherapy Handbook, Appleton & Lange, Norwalk, Conn, USA, 2nd edition, 1994.
27. M. G. Mainwaring, C. Poor, D. S. Zander, and E. Harman, “Complete remission of pulmonary spindle cell carcinoma after treatment with oral germanium sesquioxide,” Chest, vol. 117, no. 2, pp. 591–593, 2000. View at Publisher · View at Google Scholar
28. S. H. Niu, The study on novel antitumor radiopharmaceuticals, M.S. thesis, Beijing Normal University, Beijing, China, 1998.
29. M. Z. Bai, S. J. Yang, L. J. Sun, S. X. Wang, and J. Wang, “Studies on the synthesis and properties of $\beta$-(N-arylamide) ethyl germanium sesquioxides,” Chemical Journal of Chinese Universities, vol. 8, pp. 626–628, 1987.
30. S. L. Tian, K. Q. Li, Z. Y. Wang, and S. W. Zhao, “Synthesis of exo-7-oxabicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid anhydride,” Chinese Journal of Pharmaceuticals, vol. 23, p. 33, 1992.
31. J. Y. Liu, B. X. Zhang, and R. X. Li, “A study of antitumor chemotherapeutic agents-synthesis of cantharidine derivatives,” Acta Pharmaceutica Sinica, vol. 15, no. 5, pp. 271–277, 1980.
32. P. Skehan, R. Storeng, D. Scudiero, et al., “New colorimetric cytotoxicity assay for anticancer-drug screening,” Journal of the National Cancer Institute, vol. 82, no. 13, pp. 1107–1112, 1990. View at Publisher · View at Google Scholar
33. V. F. Mironov, E. M. Berliner, and T. K. Gar, “Reactions of trichlorogermane with acrylic acid and its derivatives,” Zhurnal Obshchei Khimii, vol. 37, pp. 911–912, 1967.
34. K. Asai, Miracle Cure: Organic Germanium, Japan Publications, New York, NY, USA, 1980.
35. Y. Zhang, B. G. Wang, G. Y. Zhang, and X. L. Dong, “Study on anti-tumor and mechanism of organogermanium poly-derivatives,” Carcinogenesis, Teratogenesis and Mutagenesis, vol. 16, pp. 39–42, 2004.
36. G. L. Huang, X. D. Chen, C. Xiao, and Y. B. Yan, “The inhibitory effect of germanium cinnamate on cervix cancer No.14 in mice,” China Parmaceuticals, vol. 11, pp. 42–43, 2002.
37. F. Suzuki, R. R. Brutkiewicz, and R. B. Pollard, “Ability of sera from mice treated with Ge-132, an inorganic germanium compound, to inhibit experimental murine ascites tumor,” British Journal of Cancer, vol. 52, pp. 757–763, 1985.
38. N. Kumano, T. Ishikawa, S. Koinumaru, et al., “Antitumor effect of the organogermanium compound Ge-132 on the Lewis lung carcinoma (3LL) in C57BL/6 (B6) mice,” The Tohoku Journal of Experimental Medicine, vol. 146, no. 1, pp. 97–104, 1985. View at Publisher · View at Google Scholar
39. K. H. Mu and J. Feng, “The study of the effection of Ge-132 on cultured melanocytes,” The Chinese Journal of Dermatovenereology, vol. 17, pp. 91–92, 2003.
40. K. H. Mu, J. Feng, and H. Q. Xu, “The effect of Ge-132 on ultra structure of cultured melanocytes,” Journal of Xi'an Medical University, vol. 12, no. 2, p. 148, 2000.
41. H. Dozono, K. Ikeda, and T. Onishi, “Effectiveness of Ge-132 to relieve pain and smooth home care administration for the terminal cancer patient,” Gan to Kagaku Ryoho, vol. 23, pp. 291–295, 1996.